{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:51:05Z","timestamp":1791255065517,"version":"4.1.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1038\/s41390-025-04601-0","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T09:54:27Z","timestamp":1765965267000},"page":"666-673","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cardiotoxicity in pediatric oncology: a systematic review and meta-analysis"],"prefix":"10.1038","volume":"100","author":[{"given":"N\u00f3ra","family":"Beke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xenia","family":"Jockers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rk","family":"Hern\u00e1df\u0151i","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam\u00e1s","family":"K\u00f3i","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keve","family":"Lakatos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"P\u00e1rniczky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"Hegyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikl\u00f3s","family":"Garami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,17]]},"reference":[{"key":"4601_CR1","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/bcp.13120","volume":"83","author":"KK Hutchins","year":"2017","unstructured":"Hutchins, K. K., Siddeek, H., Franco, V. I. & Lipshultz, S. E. Prevention of cardiotoxicity among survivors of childhood cancer. Br. J. Clin. Pharmacol. 83, 455\u2013465 (2017).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"4601_CR2","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1056\/NEJM199103213241205","volume":"324","author":"SE Lipshultz","year":"1991","unstructured":"Lipshultz, S. E. et al. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N. Engl. J. Med. 324, 808\u2013815 (1991).","journal-title":"N. Engl. J. Med."},{"key":"4601_CR3","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1200\/JCO.2017.76.3920","volume":"36","author":"SH Armenian","year":"2018","unstructured":"Armenian, S. H. et al. Cardiovascular disease in survivors of childhood cancer: insights into epidemiology, pathophysiology, and prevention. J. Clin. Oncol. 36, 2135\u20132144 (2018).","journal-title":"J. Clin. Oncol."},{"key":"4601_CR4","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","volume":"43","author":"AR Lyon","year":"2022","unstructured":"Lyon, A. R. et al. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO), and the International Cardio-Oncology Society (IC-OS). Eur. Heart J. 43, 4229\u20134361 (2022).","journal-title":"Eur. Heart J."},{"key":"4601_CR5","doi-asserted-by":"publisher","first-page":"966261","DOI":"10.3389\/fcvm.2022.966261","volume":"9","author":"M-Y Li","year":"2022","unstructured":"Li, M.-Y., Peng, L.-M. & Chen, X.-P. Pharmacogenomics in drug-induced cardiotoxicity: current status and the future. Front. Cardiovasc. Med. 9, 966261 (2022).","journal-title":"Front. Cardiovasc. Med."},{"key":"4601_CR6","doi-asserted-by":"publisher","first-page":"105906","DOI":"10.1016\/j.ijsu.2021.105906","volume":"88","author":"MJ Page","year":"2021","unstructured":"Page, M. J. et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int. J. Surg. 88, 105906 (2021).","journal-title":"Int. J. Surg."},{"key":"4601_CR7","unstructured":"Higgins, J. et al. Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 www.training.cochrane.org\/handbook (2022)."},{"key":"4601_CR8","doi-asserted-by":"publisher","unstructured":"Haddaway, N. R., Grainger, M. & Gray, C. citationchaser: an R package and Shiny app for forward and backward citations chasing in academic searching. Zenodo https:\/\/doi.org\/10.5281\/zenodo.4543513 (2021).","DOI":"10.5281\/zenodo.4543513"},{"key":"4601_CR9","doi-asserted-by":"crossref","unstructured":"Ouzzani, M., Hammady, H., Fedorowicz, Z. & Elmagarmid, A. Rayyan\u2014a web and mobile app for systematic reviews. Syst. Rev. 5, 210 (2016).","DOI":"10.1186\/s13643-016-0384-4"},{"key":"4601_CR10","unstructured":"EndNoteThe EndNote Team2013 Vers. EndNote 20 Philadelphia, PA: Clarivate."},{"key":"4601_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-019-0724-x","volume":"19","author":"SC Freeman","year":"2019","unstructured":"Freeman, S. C. et al. Development of an interactive web-based tool to conduct and interrogate meta-analysis of diagnostic test accuracy studies: MetaDTA. BMC Med. Res. Methodol. 19, 81 (2019).","journal-title":"BMC Med. Res. Methodol."},{"key":"4601_CR12","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s11121-021-01246-3","volume":"23","author":"JE Pustejovsky","year":"2022","unstructured":"Pustejovsky, J. E. & Tipton, E. Meta-analysis with Robust Variance Estimation: Expanding the Range of Working Models. Prev. Sci. 23, 425\u2013438 (2022).","journal-title":"Prev. Sci."},{"key":"4601_CR13","unstructured":"David, W. H. Jr, Lemeshow, S. & Sturdivant, R. X. Applied Logistic Regression 3rd edn (John Wiley & Sons, Hoboken, NJ, 2013)."},{"key":"4601_CR14","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1002\/sim.942","volume":"20","author":"CM Rutter","year":"2001","unstructured":"Rutter, C. M. & Gatsonis, C. A. A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations. Stat. Med. 20, 2865\u20132884 (2001).","journal-title":"Stat. Med."},{"key":"4601_CR15","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/biostatistics\/kxl004","volume":"8","author":"RM Harbord","year":"2007","unstructured":"Harbord, R. M., Deeks, J. J., Egger, M., Whiting, P. & Sterne, J. A. A unification of models for meta-analysis of diagnostic accuracy studies. Biostatistics 8, 239\u2013251 (2007). Erratum in: Biostatistics 9, 779 (2008).","journal-title":"Biostatistics"},{"key":"4601_CR16","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.jclinepi.2005.02.022","volume":"58","author":"BR Johannes","year":"2005","unstructured":"Johannes, B. R. et al. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews J. Clin. Epidemiol. 58, 982\u2013990 (2005).","journal-title":"J. Clin. Epidemiol."},{"key":"4601_CR17","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/j.jclinepi.2006.06.011","volume":"59","author":"H Chu","year":"2006","unstructured":"Chu, H. & Cole, S. R. Bivariate meta-analysis of sensitivity and specificity with sparse data: a generalized linear mixed model approach. J. Clin. Epidemiol. 59, 1331\u20131332 (2006). Decauthor reply 1332-3 (2006).","journal-title":"J. Clin. Epidemiol."},{"key":"4601_CR18","doi-asserted-by":"publisher","first-page":"3046","DOI":"10.1002\/sim.4040","volume":"29","author":"T Stijnen","year":"2010","unstructured":"Stijnen, T., Hamza, T. H. & Ozdemir, P. Random effects meta-analysis of event outcome in the framework of the generalized linear mixed model with applications in sparse data. Stat. Med. 29, 3046\u20133067 (2010).","journal-title":"Stat. Med."},{"key":"4601_CR19","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1200\/CCI.20.00176","volume":"5","author":"F G\u00fcnt\u00fcrk\u00fcn","year":"2021","unstructured":"G\u00fcnt\u00fcrk\u00fcn, F. et al. Artificial intelligence\u2013assisted prediction of late-onset cardiomyopathy among childhood cancer survivors. JCO Clin. Cancer Inform. 5, 459\u2013468 (2021).","journal-title":"JCO Clin. Cancer Inform."},{"key":"4601_CR20","doi-asserted-by":"publisher","first-page":"e025935","DOI":"10.1161\/JAHA.121.025935","volume":"11","author":"JM Leerink","year":"2022","unstructured":"Leerink, J. M. et al. Candidate plasma biomarkers to detect anthracycline-related cardiomyopathy in childhood cancer survivors: a case control study in the Dutch Childhood Cancer Survivor Study. J. Am. Heart Assoc. 11, e025935 (2022).","journal-title":"J. Am. Heart Assoc."},{"key":"4601_CR21","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.jaccao.2020.11.004","volume":"2","author":"MA Chaix","year":"2020","unstructured":"Chaix, M. A. et al. Machine learning identifies clinical and genetic factors associated with anthracycline cardiotoxicity in pediatric cancer survivors. JACC CardioOncol. 2, 690\u2013706 (2020).","journal-title":"JACC CardioOncol."},{"key":"4601_CR22","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s10554-022-02780-z","volume":"39","author":"AA Sanchez","year":"2022","unstructured":"Sanchez, A. A. et al. Correlating decline in left ventricular ejection fraction and longitudinal strain in pediatric cancer patients. Int. J. Cardiovasc. Imaging 39, 747\u2013755 (2022).","journal-title":"Int. J. Cardiovasc. Imaging"},{"key":"4601_CR23","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.3390\/cancers15082349","volume":"15","author":"WJ Bottinor","year":"2023","unstructured":"Bottinor, W. J. et al. Myocardial strain during surveillance screening is associated with future cardiac dysfunction among survivors of childhood, adolescent and young adult-onset cancer. Cancers 15, 2349\u20132349 (2023).","journal-title":"Cancers"},{"key":"4601_CR24","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.3390\/children10091479","volume":"10","author":"AM Ardelean","year":"2023","unstructured":"Ardelean, A. M. et al. Correlation of speckle-tracking echocardiography with traditional biomarkers in predicting cardiotoxicity among pediatric hemato-oncology patients: a comprehensive evaluation of anthracycline dosages and treatment protocols. Children 10, 1479\u20131479 (2023).","journal-title":"Children"},{"key":"4601_CR25","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1007\/s00246-023-03275-x","volume":"45","author":"M Gunsaulus","year":"2024","unstructured":"Gunsaulus, M. et al. Abnormal global longitudinal strain during anthracycline treatment predicts future cardiotoxicity in children. Pediatr. Cardiol. 45, 1750\u20131758 (2024).","journal-title":"Pediatr. Cardiol."},{"key":"4601_CR26","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/cncr.33292","volume":"127","author":"SB Dixon","year":"2020","unstructured":"Dixon, S. B. et al. Cardiac biomarkers and association with subsequent cardiomyopathy and mortality among adult survivors of childhood cancer: a report from the St. Jude Lifetime Cohort. Cancer 127, 458\u2013466 (2020).","journal-title":"Cancer"},{"key":"4601_CR27","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/S0959-8049(01)00431-2","volume":"38","author":"LCM Kremer","year":"2002","unstructured":"Kremer, L. C. M. et al. Troponin T in the first 24\u2009hours after the administration of chemotherapy and the detection of myocardial damage in children. Eur. J. Cancer 38, 686\u2013689 (2002).","journal-title":"Eur. J. Cancer"},{"key":"4601_CR28","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1097\/MPH.0b013e31826faf44","volume":"34","author":"Y Pongprot","year":"2012","unstructured":"Pongprot, Y., Sittiwangkul, R., Charoenkwan, P. & Silvilairat, S. Use of cardiac markers for monitoring of doxorubixin-induced cardiotoxicity in children with cancer. J. Pediatr. Hematol. Oncol. 34, 589\u2013595 (2012).","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"4601_CR29","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/apa.12862","volume":"104","author":"K Yl\u00e4nen","year":"2015","unstructured":"Yl\u00e4nen, K., Poutanen, T., Savukoski, T., Eerola, A. & Vettenranta, K. Cardiac biomarkers indicate a need for sensitive cardiac imaging among long-term childhood cancer survivors exposed to anthracyclines. Acta Paediatr. 104, 313\u2013319 (2015).","journal-title":"Acta Paediatr."},{"key":"4601_CR30","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.cca.2014.12.011","volume":"441","author":"MS Pourier","year":"2015","unstructured":"Pourier, M. S. et al. Values of high sensitive troponin T in long-term survivors of childhood cancer treated with anthracyclines. Clin. Chim. Acta 441, 29\u201332 (2015).","journal-title":"Clin. Chim. Acta"},{"key":"4601_CR31","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1038\/s41390-020-1049-5","volume":"89","author":"YF Cheung","year":"2020","unstructured":"Cheung, Y. F. et al. Circulating high-sensitivity troponin T and microRNAs as markers of myocardial damage during childhood leukaemia treatment. Pediatr. Res. 89, 1245\u20131252 (2020).","journal-title":"Pediatr. Res."},{"key":"4601_CR32","doi-asserted-by":"publisher","first-page":"e004653","DOI":"10.1161\/JAHA.116.004653","volume":"6","author":"KJ Leger","year":"2017","unstructured":"Leger, K. J. et al. Circulating microRNAs: potential markers of cardiotoxicity in children and young adults treated with anthracycline chemotherapy. J. Am. Heart Assoc. 6, e004653 (2017).","journal-title":"J. Am. Heart Assoc."},{"key":"4601_CR33","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/pbc.21100","volume":"49","author":"S Aggarwal","year":"2007","unstructured":"Aggarwal, S. et al. B-type natriuretic peptide as a marker for cardiac dysfunction in anthracycline-treated children. Pediatr. Blood Cancer 49, 812\u2013816 (2007).","journal-title":"Pediatr. Blood Cancer"},{"key":"4601_CR34","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.amjcard.2016.05.021","volume":"118","author":"JR Christiansen","year":"2016","unstructured":"Christiansen, J. R. et al. Utility of global longitudinal strain by echocardiography to detect left ventricular dysfunction in long-term adult survivors of childhood lymphoma and acute lymphoblastic leukemia. Am. J. Cardiol. 118, 446\u2013452 (2016).","journal-title":"Am. J. Cardiol."},{"key":"4601_CR35","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3109\/08880018.2013.851753","volume":"31","author":"EZ Basar","year":"2014","unstructured":"Basar, E. Z. et al. Are cardiac magnetic resonance imaging and radionuclide ventriculography good options against echocardiography for evaluation of anthracycline induced chronic cardiotoxicity in childhood cancer survivors?. Pediatr. Hematol. Oncol. 31, 237\u2013252 (2014).","journal-title":"Pediatr. Hematol. Oncol."},{"key":"4601_CR36","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1002\/1097-0142(19920315)69:6<1492::AID-CNCR2820690630>3.0.CO;2-3","volume":"69","author":"M Bauch","year":"1992","unstructured":"Bauch, M. et al. Atrial natriuretic peptide as a marker for doxorubicin-induced cardiotoxic effects. Cancer 69, 1492\u20131497 (1992).","journal-title":"Cancer"},{"key":"4601_CR37","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/mpo.1135","volume":"36","author":"G Bossi","year":"2001","unstructured":"Bossi, G. et al. Echocardiographic evaluation of patients cured of childhood cancer: a single center study of 117 subjects who received anthracyclines. Med. Pediatr. Oncol. 36, 593\u2013600 (2001).","journal-title":"Med. Pediatr. Oncol."},{"key":"4601_CR38","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1002\/pbc.24404","volume":"60","author":"TR Brown","year":"2013","unstructured":"Brown, T. R. et al. Anthracycline induced cardiac toxicity in pediatric Ewing sarcoma: a longitudinal study. Pediatr. Blood Cancer 60, 842\u2013848 (2013).","journal-title":"Pediatr. Blood Cancer"},{"key":"4601_CR39","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/mpo.2950250305","volume":"25","author":"F Fink","year":"1995","unstructured":"Fink, F. et al. Cardiac troponin T and creatine kinase MB mass concentrations in children receiving anthracycline chemotherapy. Med. Pediatr. Oncol. 25, 185\u2013189 (1995).","journal-title":"Med. Pediatr. Oncol."},{"key":"4601_CR40","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1203\/00006450-199603000-00020","volume":"39","author":"D De Wolf","year":"1996","unstructured":"De Wolf, D. et al. Dobutamine stress echocardiography in the evaluation of late anthracycline cardiotoxicity in childhood cancer survivors. Pediatr. Res. 39, 504\u2013512 (1996).","journal-title":"Pediatr. Res."},{"key":"4601_CR41","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.4103\/0366-6999.233950","volume":"131","author":"HM Hu","year":"2018","unstructured":"Hu, H. M., Zhang, X. L., Zhang, W. L., Huang, D. S. & Du, Z. D. Detection of subclinical anthracyclines\u2019 cardiotoxicity in children with solid tumor. Chin. Med. J. 131, 1450\u20131456 (2018).","journal-title":"Chin. Med. J."},{"key":"4601_CR42","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1002\/mpo.2950110308","volume":"11","author":"SJ Goldberg","year":"1983","unstructured":"Goldberg, S. J., Hutter, J. J., Feldman, L. & Goldberg, S. M. Two sensitive echocardiographic techniques for detecting doxorubicin toxicity. Med. Pediatr. Oncol. 11, 3172\u20133177 (1983).","journal-title":"Med. Pediatr. Oncol."},{"key":"4601_CR43","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s004310100830","volume":"160","author":"M Hauser","year":"2001","unstructured":"Hauser, M., Gibson, B. & Wilson, N. Diagnosis of anthracycline-induced late cardiomyopathy by exercise-spiroergometry and stress-echocardiography. Eur. J. Pediatr. 160, 607\u2013610 (2001).","journal-title":"Eur. J. Pediatr."},{"key":"4601_CR44","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/S0002-9149(00)01222-4","volume":"86","author":"M Ishii","year":"2000","unstructured":"Ishii, M. et al. Sequential evaluation of left ventricular myocardial performance in children after anthracycline therapy. Am. J. Cardiol. 86, 1279\u20131281 (2000).","journal-title":"Am. J. Cardiol."},{"key":"4601_CR45","doi-asserted-by":"publisher","first-page":"e107","DOI":"10.1097\/MPH.0000000000000491","volume":"38","author":"F Kaya","year":"2016","unstructured":"Kaya, F. et al. Growth-differentiation factor-15 and tissue doppler imaging in detection of anthracycline-induced cardiomyopathy during therapy of childhood cancers. J. Pediatr. Hematol. Oncol. 38, e107\u2013e112 (2016).","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"4601_CR46","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1081\/CNV-100103130","volume":"19","author":"P Mathew","year":"2001","unstructured":"Mathew, P. et al. Is there a potential role for serum cardiac troponin I as a marker for myocardial dysfunction in pediatric patients receiving anthracycline-based therapy? A pilot study. Cancer Invest. 19, 352\u2013359 (2001).","journal-title":"Cancer Invest."},{"key":"4601_CR47","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1200\/JCO.1999.17.4.1208","volume":"17","author":"LCM Kremer","year":"1999","unstructured":"Kremer, L. C. M. et al. Indium-111\u2013antimyosin scintigraphy in the early detection of heart damage after anthracycline therapy in children. J. Clin. Oncol. 17, 1208\u20131208 (1999).","journal-title":"J. Clin. Oncol."},{"key":"4601_CR48","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1067\/mhj.2000.108237","volume":"140","author":"L Lanzarini","year":"2000","unstructured":"Lanzarini, L., Bossi, G., Laudisa, M. L., Klersy, C. & Aric\u00f2, M. Lack of clinically significant cardiac dysfunction during intermediate dobutamine doses in long-term childhood cancer survivors exposed to anthracyclines. Am. Heart J. 140, 315\u2013323 (2000).","journal-title":"Am. Heart J."},{"key":"4601_CR49","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s10554-020-01970-x","volume":"37","author":"RW Loar","year":"2020","unstructured":"Loar, R. W. et al. Assessing the left atrium of childhood cancer survivors. Int. J. Cardiovasc. Imaging 37, 155\u2013162 (2020).","journal-title":"Int. J. Cardiovasc. Imaging"},{"key":"4601_CR50","doi-asserted-by":"crossref","unstructured":"Mahdavi, C. et al. Anthracycline-induced cardiothoxicity in children cancer patients: an imaging study by two-dimensional global longitudinal strain using automated function imaging technique. J. Compr. Pediatr. 9, e59701 (2018).","DOI":"10.5812\/compreped.59701"},{"key":"4601_CR51","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jnci.2016.12.001","volume":"29","author":"E Moussa","year":"2017","unstructured":"Moussa, E. et al. Risk stratification and pattern of cardiotoxicity in pediatric Ewing sarcoma. J. Egypt. Natl. Cancer Inst. 29, 53\u201356 (2017).","journal-title":"J. Egypt. Natl. Cancer Inst."},{"key":"4601_CR52","doi-asserted-by":"crossref","unstructured":"Niemel\u00e4, J. et al. Cardiac function after cardiotoxic treatments for childhood cancer\u2014left ventricular longitudinal strain in screening. Front. Cardiovasc. Med. 8, 715953 (2021).","DOI":"10.3389\/fcvm.2021.715953"},{"key":"4601_CR53","doi-asserted-by":"publisher","first-page":"e374","DOI":"10.1097\/MPH.0000000000002156","volume":"44","author":"V Sitte","year":"2022","unstructured":"Sitte, V. et al. Advanced imaging and new cardiac biomarkers in long-term follow-up after childhood cancer. J. Pediatr. Hematol. Oncol. 44, e374\u2013e380 (2022).","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"4601_CR54","doi-asserted-by":"publisher","first-page":"452","DOI":"10.3390\/life12030452","volume":"12","author":"M Pourier","year":"2022","unstructured":"Pourier, M. et al. Cardiac events in childhood cancer survivors treated with anthracyclines: the value of previous myocardial strain measurement. Life 12, 452 (2022).","journal-title":"Life"},{"key":"4601_CR55","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1080\/08880010050122799","volume":"17","author":"VV Prestor","year":"2000","unstructured":"Prestor, V. V., Rakovec, P., Kozelj, M. & Jereb, B. Late cardiac damage of anthracycline therapy for acute lymphoblastic leukemia in childhood. Pediatr. Hematol. Oncol. 17, 527\u2013540 (2000).","journal-title":"Pediatr. Hematol. Oncol."},{"key":"4601_CR56","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/00043426-199205000-00010","volume":"14","author":"GG Sandor","year":"1992","unstructured":"Sandor, G. G. et al. Early prediction of anthracycline cardiomyopathy using standard M-mode and digitized echocardiography. J. Pediatr. Hematol. Oncol. 14, 151\u2013157 (1992).","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"4601_CR57","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1179\/102453312X13376952196412","volume":"17","author":"LM Sherief","year":"2012","unstructured":"Sherief, L. M. et al. Biomarkers and early detection of late onset anthracycline-induced cardiotoxicity in children. Hematology 17, 151\u2013156 (2012).","journal-title":"Hematology"},{"key":"4601_CR58","doi-asserted-by":"crossref","unstructured":"Yu, H. et al. New three-dimensional speckle-tracking echocardiography identifies global impairment of left ventricular mechanics with a high sensitivity in childhood cancer survivors. J. Am. Soc. Echocardiogr. 26, 846\u2013852 (2013).","DOI":"10.1016\/j.echo.2013.04.018"},{"key":"4601_CR59","doi-asserted-by":"crossref","unstructured":"von Scheidt, F. et al. Left ventricular strain analysis during submaximal semisupine bicycle exercise stress echocardiography in childhood cancer survivors. J. Am. Soc. Echocardiogr. 11, e025324 (2022).","DOI":"10.1161\/JAHA.122.025324"},{"key":"4601_CR60","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1097\/FTD.0000000000001077","volume":"45","author":"A Siemens","year":"2023","unstructured":"Siemens, A., Rassekh, S. R., Ross, C. J. D. & Carleton, B. C. Development of a dose-adjusted polygenic risk model for anthracycline-induced cardiotoxicity. Ther. Drug Monit. 45, 337\u2013344 (2023).","journal-title":"Ther. Drug Monit."},{"key":"4601_CR61","doi-asserted-by":"publisher","first-page":"e132","DOI":"10.1097\/MPH.0b013e318212eb6b","volume":"33","author":"AAG Tantawy","year":"2011","unstructured":"Tantawy, A. A. G., Elmasry, O. A., Shaaban, M., Toaima, D. N. & El Shahat, A. M. Radionuclide ventriculography detects early anthracycline cardiotoxity in children with Hodgkin lymphoma. J. Pediatr. Hematol. Oncol. 33, e132\u2013e137 (2011).","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"4601_CR62","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/0167-5273(92)90297-G","volume":"36","author":"RYJ Tamminga","year":"1992","unstructured":"Tamminga, R. Y. J., Bink-Boelkens, M. T. E. & Kievit, J. Ventricular late potentials: another expression of cardiotoxicity of cytostatic drugs in children?. Int. J. Cardiol. 36, 283\u2013288 (1992).","journal-title":"Int. J. Cardiol."},{"key":"4601_CR63","doi-asserted-by":"crossref","unstructured":"Foulkes, S. et al. Exercise cardiovascular magnetic resonance reveals reduced cardiac reserve in pediatric cancer survivors with impaired cardiopulmonary fitness. J. Cardiovas. Magn. Reson. 22, 64 (2022).","DOI":"10.1186\/s12968-020-00658-4"},{"key":"4601_CR64","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/j.1651-2227.2006.00174.x","volume":"96","author":"B Erkus","year":"2007","unstructured":"Erkus, B. et al. Early prediction of anthracycline induced cardiotoxicity. Acta Paediatrica 96, 506\u2013509 (2007).","journal-title":"Acta Paediatrica"},{"key":"4601_CR65","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1046\/j.1328-8067.2001.01526.x","volume":"44","author":"D FukuMi","year":"2002","unstructured":"FukuMi, D., Uchikoba, Y., Maeda, M. & Ogawa, S. Longitudinal evaluation of anthracycline cardiotoxicity by signal-averaged electrocardiography in children with cancer. Pediatr. Int. 44, 134\u2013140 (2002).","journal-title":"Pediatr. Int."},{"key":"4601_CR66","doi-asserted-by":"crossref","unstructured":"Yu, A. F. et al. Two-dimensional speckle tracking echocardiography detects subclinical left ventricular systolic dysfunction among adult survivors of childhood, adolescent, and young adult cancer. Biomed Res. Int. 2016, 9363951 (2016).","DOI":"10.1155\/2016\/9363951"},{"key":"4601_CR67","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.1200\/JCO.2011.40.3584","volume":"30","author":"GT Armstrong","year":"2012","unstructured":"Armstrong, G. T. et al. Screening adult survivors of childhood cancer for cardiomyopathy: comparison of echocardiography and cardiac magnetic resonance imaging. J. Clin. Oncol. 30, 2876\u20132884 (2012).","journal-title":"J. Clin. Oncol."},{"key":"4601_CR68","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1136\/jim-2020-001373","volume":"68","author":"D Mokshagundam","year":"2020","unstructured":"Mokshagundam, D. et al. Cardiac changes in pediatric cancer survivors. J. Investig. Med. 68, 1364\u20131369 (2020).","journal-title":"J. Investig. Med."},{"key":"4601_CR69","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1097\/FJC.0000000000001479","volume":"82","author":"Y Li","year":"2023","unstructured":"Li, Y. et al. Potential biomarker of acute anthracycline-induced cardiotoxicity among children with acute lymphoblastic leukemia: cardiac adriamycin-responsive protein. J. Cardiovasc. Pharmacol. 82, 489\u2013495 (2023).","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"4601_CR70","doi-asserted-by":"crossref","unstructured":"Masood, I. et al. Left ventricle size correlates with peak exercise capacity in pediatric cancer survivors exposed to anthracycline chemotherapy. Pediatr. Cardiol. 45, 1493\u20131502 (2023).","DOI":"10.1007\/s00246-023-03192-z"},{"key":"4601_CR71","doi-asserted-by":"crossref","unstructured":"Hayakawa, H. et al. Plasma levels of natriuretic peptides in relation to doxorubicin-induced cardiotoxicity and cardiac function in children with cancer. Med Pediatr Oncol. 37, 4\u20139 (2001).","DOI":"10.1002\/mpo.1155"},{"key":"4601_CR72","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1002\/pbc.24505","volume":"60","author":"H Visscher","year":"2013","unstructured":"Visscher, H. et al. Validation of variants inSLC28A3andUGT1A6as genetic markers predictive of anthracycline-induced cardiotoxicity in children. Pediatr. Blood Cancer 60, 1375\u20131381 (2013).","journal-title":"Pediatr. Blood Cancer"},{"key":"4601_CR73","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.2217\/pgs.15.61","volume":"16","author":"H Visscher","year":"2015","unstructured":"Visscher, H. et al. Genetic variants in SLC22A17 and SLC22A7 are associated with anthracycline-induced cardiotoxicity in children. Pharmacogenomics 16, 1065\u20131076 (2015).","journal-title":"Pharmacogenomics"},{"key":"4601_CR74","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1007\/s12350-015-0309-y","volume":"24","author":"M Jos\u00e9","year":"2017","unstructured":"Jos\u00e9, M. et al. Assessment of late anthracycline-induced cardiotoxicity by 123I-mIBG cardiac scintigraphy in patients treated during childhood and adolescence. J. Nucl. Cardiol. 24, 256\u2013264 (2017).","journal-title":"J. Nucl. Cardiol."},{"key":"4601_CR75","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3109\/08880018.2011.563772","volume":"28","author":"K Oztarhan","year":"2011","unstructured":"Oztarhan, K. et al. The value of echocardiography versus cardiac troponin I levels in the early detection of anthracycline cardiotoxicity in childhood acute leukemia: prospective evaluation of a 7-year-long clinical follow-up. Pediatr. Hematol. Oncol. 28, 380\u2013394 (2011).","journal-title":"Pediatr. Hematol. Oncol."},{"key":"4601_CR76","doi-asserted-by":"crossref","unstructured":"McOwan, T. N. et al. Evaluating anthracycline cardiotoxicity associated single nucleotide polymorphisms in a paediatric cohort with early onset cardiomyopathy. Cardiooncology 6, 5 (2020).","DOI":"10.1186\/s40959-020-00060-0"},{"key":"4601_CR77","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1007\/PL00021001","volume":"23","author":"B \u00d6cal","year":"2002","unstructured":"\u00d6cal, B. et al. Myocardial performance index combining systolic and diastolic myocardial performance in doxorubicin-treated patients and its correlation to conventional echo\/Doppler indices. Pediatr. Cardiol. 23, 522\u2013527 (2002).","journal-title":"Pediatr. Cardiol."},{"key":"4601_CR78","doi-asserted-by":"crossref","unstructured":"Oatmen, K. E. et al. Identification of a novel microRNA profile in pediatric patients with cancer treated with anthracycline chemotherapy. Am. J. Physiol. Heart Circ. Physiol. 315, H1443\u2013H1452 (2018).","DOI":"10.1152\/ajpheart.00252.2018"},{"key":"4601_CR79","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1007\/s12012-022-09755-5","volume":"22","author":"Z Liu","year":"2022","unstructured":"Liu, Z. et al. Development and validation of a diagnostic nomogram to predict the anthracycline-induced early cardiotoxicity in children with hematological tumors. Cardiovasc. Toxicol. 22, 802\u2013812 (2022).","journal-title":"Cardiovasc. Toxicol."},{"key":"4601_CR80","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1002\/pbc.22371","volume":"54","author":"Elske Sieswerda","year":"2009","unstructured":"Elske Sieswerda et al. Exercise echocardiography in asymptomatic survivors of childhood cancer treated with anthracyclines: a prospective follow-up study. Pediatr. Blood Cancer 54, 579\u2013584 (2009).","journal-title":"Pediatr. Blood Cancer"},{"key":"4601_CR81","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1272\/jnms.77.234","volume":"77","author":"Y Uchikoba","year":"2010","unstructured":"Uchikoba, Y., Fukazawa, R., Ohkubo, T., Maeda, M. & Ogawa, S. Early detection of subclinical anthracycline cardiotoxicity on the basis of QT dispersion. J. Nippon Med. Sch. 77, 234\u2013243 (2010).","journal-title":"J. Nippon Med. Sch."},{"key":"4601_CR82","doi-asserted-by":"crossref","unstructured":"Toro-Salazar, O. H. et al. Feasibility of echocardiographic techniques to detect subclinical cancer therapeutics\u2013related cardiac dysfunction among high-dose patients when compared with cardiac magnetic resonance imaging. J. Am. Soc. Echocardiogr. 29, 119\u2013131 (2016).","DOI":"10.1016\/j.echo.2015.10.008"},{"key":"4601_CR83","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.jaccao.2022.09.009","volume":"5","author":"P Singh","year":"2023","unstructured":"Singh, P. et al. Haptoglobin gene expression and anthracycline-related cardiomyopathy in childhood cancer survivors. JACC Cardiooncol. 5, 392\u2013401 (2023).","journal-title":"JACC Cardiooncol."},{"key":"4601_CR84","doi-asserted-by":"crossref","unstructured":"Narayan, H. K. et al. Atlas-based measures of left ventricular shape may improve characterization of adverse remodeling in anthracycline-exposed childhood cancer survivors: a cross-sectional imaging study. Cardiooncology 6, 13 (2020).","DOI":"10.1186\/s40959-020-00069-5"},{"key":"4601_CR85","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.jaccao.2023.06.003","volume":"5","author":"Remy Merkx","year":"2023","unstructured":"Remy Merkx et al. Extensive cardiac function analyses using contemporary echocardiography in childhood cancer survivors. JACC Cardiooncol. 5, 472\u2013485 (2023).","journal-title":"JACC Cardiooncol."},{"key":"4601_CR86","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ijcard.2022.06.067","volume":"363","author":"J Zhan","year":"2022","unstructured":"Zhan, J. et al. Deterioration in myocardial work indices precedes changes in global longitudinal strain following anthracycline chemotherapy. Int. J. Cardiol. 363, 171\u2013178 (2022).","journal-title":"Int. J. Cardiol."},{"key":"4601_CR87","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jaccao.2020.11.013","volume":"3","author":"JM Leerink","year":"2021","unstructured":"Leerink, J. M. et al. Refining the 10-year prediction of left ventricular systolic dysfunction in long-term survivors of childhood cancer. JACC Cardiooncol. 3, 62\u201372 (2021).","journal-title":"JACC Cardiooncol."},{"key":"4601_CR88","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s00380-023-02312-2","volume":"39","author":"Y Hosono","year":"2023","unstructured":"Hosono, Y. et al. Assessment of anthracycline-induced cardiotoxicity in childhood cancer survivors during long-term follow-up using strain analysis and intraventricular pressure gradient measurements. Heart Vessels 39, 105\u2013116 (2023).","journal-title":"Heart Vessels"},{"key":"4601_CR89","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1007\/s002469900461","volume":"20","author":"MB Goens","year":"1999","unstructured":"Goens, M. B., Karr, S. S., Seibel, N. & Martin, G. R. Ultrasound myocardial tissue characterization by integrated backscatter in children treated with anthracyclines. Pediatr. Cardiol. 20, 264\u2013270 (1999).","journal-title":"Pediatr. Cardiol."},{"key":"4601_CR90","first-page":"430","volume":"85","author":"J Allen","year":"2001","unstructured":"Allen, J., Thomson, J. D. R., Lewis, I. J. & Gibbs, J. L. Mitral regurgitation after anthracycline treatment for childhood malignancy. Br. Heart J. 85, 430\u2013432 (2001).","journal-title":"Br. Heart J."},{"key":"4601_CR91","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s10147-012-0458-9","volume":"18","author":"A Ruggiero","year":"2012","unstructured":"Ruggiero, A. et al. Myocardial performance index and biochemical markers for early detection of doxorubicin-induced cardiotoxicity in children with acute lymphoblastic leukaemia. Int. J. Clin. Oncol. 18, 927\u2013933 (2012).","journal-title":"Int. J. Clin. Oncol."},{"key":"4601_CR92","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1038\/s41591-021-01458-8","volume":"27","author":"P Hegyi","year":"2021","unstructured":"Hegyi, P., Er\u0151ss, B., Izb\u00e9ki, F., P\u00e1rniczky, A. & Szentesi, A. Accelerating the translational medicine cycle: the Academia Europaea pilot. Nat. Med. 27, 1317\u20131319 (2021).","journal-title":"Nat. Med."},{"key":"4601_CR93","doi-asserted-by":"crossref","unstructured":"Hegyi, P. et al. Academia Europaea position paper on translational medicine: the cycle model for translating scientific results into community benefits. J. Clin. Med. 9, 1532 (2020).","DOI":"10.3390\/jcm9051532"},{"key":"4601_CR94","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1182\/hematology.2022000342","volume":"2022","author":"W Bottinor","year":"2022","unstructured":"Bottinor, W. & Chow, E. J. Mitigating, monitoring, and managing long-term chemotherapy- and radiation-induced cardiac toxicity. Hematol. Am. Soc. Hematol. Educ. Program 2022, 251\u2013258 (2022).","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"4601_CR95","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-11353-9","volume":"23","author":"TW Kouwenberg","year":"2023","unstructured":"Kouwenberg, T. W. et al. Acute and early-onset cardiotoxicity in children and adolescents with cancer: a systematic review. BMC Cancer 23, 866 (2023).","journal-title":"BMC Cancer"},{"key":"4601_CR96","doi-asserted-by":"publisher","first-page":"471","DOI":"10.2217\/fca.15.16","volume":"11","author":"MG Khouri","year":"2015","unstructured":"Khouri, M. G., Klein, M. R., Velazquez, E. J. & Jones, L. W. Current and emerging modalities for detection of cardiotoxicity in cardio-oncology. Future Cardiol. 11, 471\u2013484 (2015).","journal-title":"Future Cardiol."},{"key":"4601_CR97","doi-asserted-by":"publisher","first-page":"296","DOI":"10.31083\/j.rcm2410296","volume":"24","author":"Y Zheng","year":"2023","unstructured":"Zheng, Y. et al. Machine learning in cardio-oncology: new insights from an emerging discipline. Rev. Cardiovasc. Med. 24, 296 (2023).","journal-title":"Rev. Cardiovasc. Med."},{"key":"4601_CR98","doi-asserted-by":"crossref","unstructured":"Zhou, Y. et al. Machine learning\u2013based risk assessment for cancer therapy\u2013related cardiac dysfunction in 4300 longitudinal oncology patients. J. Am. Heart. Assoc. 9, e019628 (2020).","DOI":"10.1161\/JAHA.120.019628"},{"key":"4601_CR99","doi-asserted-by":"publisher","first-page":"787","DOI":"10.3390\/diagnostics15060787","volume":"15","author":"LC Nechita","year":"2025","unstructured":"Nechita, L. C. et al. AI and smart devices in cardio-oncology: advancements in cardiotoxicity prediction and cardiovascular monitoring. Diagnostics 15, 787 (2025).","journal-title":"Diagnostics"},{"key":"4601_CR100","doi-asserted-by":"publisher","first-page":"6295","DOI":"10.3390\/jcm12196295","volume":"12","author":"M Cronin","year":"2023","unstructured":"Cronin, M. et al. Multimodal imaging of cancer therapy-related cardiac dysfunction in breast cancer\u2014a state-of-the-art review. J. Clin. Med. 12, 6295\u20136295 (2023).","journal-title":"J. Clin. Med."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04601-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04601-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04601-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:03:01Z","timestamp":1791252181000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04601-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":100,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["4601"],"URL":"https:\/\/doi.org\/10.1038\/s41390-025-04601-0","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,17]]},"assertion":[{"value":"9 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"In preparing this manuscript, the authors employed ChatGPT (OpenAI, version 4, 2024) to assist in improving the readability of the text. The content was subsequently reviewed and refined by the authors, who take full responsibility for the content of the publication.","order":2,"name":"Ethics","label":"Declaration of generative AI and AI-assisted technologies in the writing process","group":{"name":"EthicsHeading","label":"Ethics"}}]}}